A Strategic Roadmap to Harness the Power of Artificial Intelligence in Medicines Regulation In a bold leap towards innovation, the European Medicines Agency (EMA) and the Heads of Medicines Agencies…
In a strategic move that is set to reshape the landscape of the biopharmaceutical industry, Pfizer has announced its monumental $43 billion acquisition of Seagen. This landmark deal marks a…
In a groundbreaking move to advance cancer therapeutics, AstraZeneca, a global pharmaceutical giant, has recently entered into a strategic collaboration with Absci, a leading synthetic biology company. The deal, valued…
Groundbreaking Gene-Editing Therapy Receives Green Light, Signaling a New Era in Sickle Cell Treatment Date: 12 December 2023 Introduction: In a landmark decision, the U.S. Food and Drug Administration (FDA)…
MHRA Approves CASGEVY™ for Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia, Marking a Milestone in Precision Medicine Date: 7 December 2023 Introduction: In a historic move that signals a new…